haplo-sct for older patients with aml/hr-mds: should age be a barrier to transplantation?
Published 5 months ago • 66 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
3:01
frailty index as a predictor of sct outcomes in elderly patients
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
2:25
optimizing haplo-sct for the treatment of aml
-
4:36
aml haplo-hsct outcomes
-
2:13
haploidentical sct for the treatment of secondary aml
-
1:46
optimizing conditioning regimens in patients with aml undergoing allosct
-
1:41
how donor age impacts outcomes in patients with aml undergoing allosct
-
1:13
molecular mrd as a prognostic marker for aml patients with mutated cebpa
-
1:14:04
hsct haematopoietic stem cell transplantation bcop 2021
-
9:42
bone marrow transplant with 50% matching donor successful
-
1:27
first-line tagraxofusp followed by allosct in bpdcn: a case study
-
1:09
outcomes following haploidentical & cord blood transplantation in pediatric patients with aml
-
1:13
outcomes following fd & nfd related donor haplo transplantation for patients with acute leukemias
-
2:00
haploidentical transplantation for aml with mrd at transplantation
-
2:17
the need to improve the quality of life of patients with aml undergoing allosct
-
4:39
aml & mds: mac or ric?
-
2:23
patient selection for autosct in hl & increasing cr rate before autosct with novel salvage regimens
-
3:10
the efficacy of haploidentical transplantation in aml and all
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
1:45
long-term survival of patients with cll treated with ibrutinib compared to age-matched controls
-
2:16
late effects of hsct in young patients with all: transition to adult services & long-term follow-up
-
1:33
sorafenib as maintenance therapy for patients with transplant-ineligible or post-allosct aml